(Q39478089)

12 September 2017

Effectiveness of a hepatitis A vaccination program for migrant children in Amsterdam, The Netherlands (1992-2004). (English)

1 reference

12 September 2017

0 references

1 reference

Sonder GJ

1

1 reference

12 September 2017

Bovée LP

2

1 reference

12 September 2017

Baayen TD

3

1 reference

12 September 2017

Coutinho RA

4

1 reference

12 September 2017

van den Hoek JA

5

1 reference

12 September 2017

language of work or name

English

0 references

publication date

18 April 2006

1 reference

12 September 2017

1 reference

12 September 2017

24

1 reference

12 September 2017

23

1 reference

12 September 2017

4962-4968

1 reference

Transmission of hepatitis A in hamburg, germany, 1998-1999--A prospective population based study

12 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.03.075

Prevention of hepatitis A with the hepatitis A vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.03.075

Hepatitis a molecular epidemiology in the United States, 1996-1997: sources of infection and implications of vaccination policy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.03.075

Hepatitis A virus immunity and seroconversion among contacts of acute hepatitis A patients in Amsterdam, 1996-2000: an evaluation of current prevention policy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.03.075

Two years' prospective collection of molecular and epidemiological data shows limited spread of hepatitis A virus outside risk groups in Amsterdam, 2000-2002.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.03.075

Inactivated hepatitis A vaccine booster given >/=24 months after the primary dose

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.03.075

Pharmaco-economic evaluation of targeted hepatitis A vaccination for children of ethnic minorities in Amsterdam (The Netherlands).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.03.075

The prevalence of antibodies to hepatitis A virus and its determinants in The Netherlands: a population-based survey

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.03.075

Seroprevalence of hepatitis A virus antibodies in Turkish and Moroccan children in Rotterdam

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.03.075

Evaluation of the hepatitis B antenatal screening and neonatal immunization program in Amsterdam, 1993-1998.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.03.075

10.1016/J.VACCINE.2006.03.075

7 January 2021

Identifiers

DOI

1 reference

12 September 2017

1 reference